These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

764 related items for PubMed ID: 29479739

  • 1. Denosumab-related osteonecrosis of the jaw following non-surgical periodontal therapy: A case report.
    Diniz-Freitas M, Fernández-Feijoo J, Diz Dios P, Pousa X, Limeres J.
    J Clin Periodontol; 2018 May; 45(5):570-577. PubMed ID: 29479739
    [Abstract] [Full Text] [Related]

  • 2. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
    Svejda B, Muschitz Ch, Gruber R, Brandtner Ch, Svejda Ch, Gasser RW, Santler G, Dimai HP.
    Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
    [Abstract] [Full Text] [Related]

  • 3. Denosumab-related osteonecrosis of the jaw: a report of 2 cases and review of the literature.
    Chehal H, Nikitakis NG, Islam MN, Goodchild JH, Mordini L, Bhattacharyya I.
    Gen Dent; 2019 Feb; 67(1):42-46. PubMed ID: 30644830
    [Abstract] [Full Text] [Related]

  • 4. Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis.
    Bagan J, Peydró A, Calvo J, Leopoldo M, Jiménez Y, Bagan L.
    Oral Dis; 2016 May; 22(4):324-9. PubMed ID: 26818808
    [Abstract] [Full Text] [Related]

  • 5. Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study.
    Ristow O, Rückschloß T, Müller M, Berger M, Kargus S, Pautke C, Engel M, Hoffmann J, Freudlsperger C.
    J Craniomaxillofac Surg; 2019 Mar; 47(3):491-499. PubMed ID: 30642734
    [Abstract] [Full Text] [Related]

  • 6. Osteonecrosis of the jaw in patients transitioning from bisphosphonates to denosumab treatment for osteoporosis.
    Voss PJ, Steybe D, Poxleitner P, Schmelzeisen R, Munzenmayer C, Fuellgraf H, Stricker A, Semper-Hogg W.
    Odontology; 2018 Oct; 106(4):469-480. PubMed ID: 29713913
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Management of Medication-Related Osteonecrosis of the Jaw.
    Williams WB, O'Ryan F.
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):517-25. PubMed ID: 26515735
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Bisphosphonate and denosumab-related osteonecrosis of the jaw: Epidemiology, diagnosis and management].
    Dupic G, Collangettes D, Dillies AF, Calvet L, Tournilhac O, Bay JO, Mahammedi H.
    Bull Cancer; 2015 Dec; 102(12):1010-9. PubMed ID: 26607453
    [Abstract] [Full Text] [Related]

  • 12. Osteonecrosis of the jaw in patients treated with denosumab: A multicenter case series.
    Aljohani S, Gaudin R, Weiser J, Tröltzsch M, Ehrenfeld M, Kaeppler G, Smeets R, Otto S.
    J Craniomaxillofac Surg; 2018 Sep; 46(9):1515-1525. PubMed ID: 29983309
    [Abstract] [Full Text] [Related]

  • 13. Key insights into antiresorptive drug use and osteonecrosis in osteoporotic patients undergoing tooth extractions: A clinical and CBCT assessment.
    Moreno-Rabié C, Fontenele RC, Oliveira-Santos N, Nogueira-Reis F, Van den Wyngaert T, Jacobs R.
    Osteoporos Int; 2024 Aug; 35(8):1431-1440. PubMed ID: 38767743
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab.
    Wick A, Bankosegger P, Otto S, Hohlweg-Majert B, Steiner T, Probst F, Ristow O, Pautke C.
    Clin Oral Investig; 2022 Mar; 26(3):2839-2852. PubMed ID: 34812959
    [Abstract] [Full Text] [Related]

  • 18. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
    Owosho AA, Liang STY, Sax AZ, Wu K, Yom SK, Huryn JM, Estilo CL.
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial peptide gene expression in medication-related osteonecrosis of the jaw.
    Thiel Y, Ghayor C, Lindhorst D, Essig H, Weber F, Rücker M, Schumann P.
    Pathol Res Pract; 2020 Dec; 216(12):153245. PubMed ID: 33065485
    [Abstract] [Full Text] [Related]

  • 20. [Progress on medication-related osteonecrosis of the jaw].
    Wang QZ, Liu JY, Pan J.
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2018 Oct 01; 36(5):568-572. PubMed ID: 30465354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.